Results 81 to 90 of about 3,191 (210)

Optimizing Building Energy Systems Using Generalized Disjunctive Programming: Improving Model Precision and Decision‐Making Efficiency

International Journal of Energy Research, Volume 2026, Issue 1, 2026.
This paper examines the optimization of building energy systems (BESs) through the lens of generalized disjunctive programming (GDP), a methodology that streamlines the modeling of intricate logical structures and discrete decisions. The study concentrates on three pivotal aspects of BES optimization: the imposition of minimum part‐load constraints ...
Yi Nie, Thomas Schreiber, Dirk Müller, Rajashik Paul   +3 more
wiley   +1 more source

University Campus as a Living Laboratory for Cleaner Energy Transition: Integrating High‐Resolution Solar Assessment With Policy Framework for Institutional Decarbonization

International Journal of Energy Research, Volume 2026, Issue 1, 2026.
Universities represent critical yet underutilized platforms for climate change mitigation through renewable energy transitions, yet few have integrated high‐resolution spatial analytics with actionable policy frameworks for institutional decarbonization.
Mehmet Fatih Döker, Masoud Minaei, Cem Kırlangıçoğlu, Esra Özdoruk, Cheng Du   +4 more
wiley   +1 more source

Meta-analysis of trials comparing standard antiemetic treatment (SAT) with aprepitant containing antiemetic regimens (ACAR) for prevention of chemotherapy-induced nausea and vomiting (CINV). [PDF]

, 2014
171 Background: Various randomized controlled trials (RCTs) have shown improved outcomes with addition of aprepitant to standard antiemetic treatment (SAT) in preventing CINV.
Roberto Pili, Hassan Hatoum, Omar Al Ustwani, Neha Gupta, Pongwut Danchaivijitr, Katy Wang   +5 more
core   +1 more source

Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial

International Journal of Women's Health, 2023
Apichaya Sukpiriyagul,1 Ratiporn Chartchaiyarerk,1 Paluekpon Tabtipwon,1 Buppa Smanchat,1 Sinart Prommas,1 Kornkarn Bhamarapravatana,2 Komsun Suwannarurk3 1Department of Obstetrics and Gynecology, Bhumibol Adulyadej Hospital, Royal Thai Air Force Bangkok
Sukpiriyagul A, Chartchaiyarerk R, Tabtipwon P, Smanchat B, Prommas S, Bhamarapravatana K, Suwannarurk K   +6 more
doaj  

A Comprehensive Energy, Exergy, Exergoenvironmental, Economic, and Indoor Environmental Quality Assessment of a Split Air Conditioning System

International Journal of Energy Research, Volume 2026, Issue 1, 2026.
This study presents a comprehensive experimental and multicriteria performance assessment of a 9000 BTU/h split‐type air conditioning system operating with R410A, integrating energy, exergy, environmental (total equivalent warming impact [TEWI] and life cycle climate performance [LCCP]), exergoenvironmental, economic, uncertainty, and indoor ...
Zafer Cingiz, Claire Gao
wiley   +1 more source

The emerging role of olanzapine in paediatric CINV control: A review

Medicine, 2022
Chemotherapy-induced nausea and vomiting (CINV) is a serious side effect of chemotherapy that negatively impacts the quality of life of oncological patients and is associated with the emetogenic risk specific to administered chemotherapy. Current practice guidelines on the use of antiemetics in CINV include the option of adding olanzapine to antiemetic
openaire   +2 more sources

Efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastrointestinal and colorectal cancers. [PDF]

, 2016
222 Background: Rolapitant (VARUBI) is a selective, long-acting neurokinin-1 receptor antagonist (RA) for the prevention of CINV. Rolapitant effectively prevented CINV in phase 3 trials of patients (pts) receiving highly or moderately emetogenic ...
Daniel Powers, Martin Chasen, Bernardo Leon Rapoport, Ian D. Schnadig, Lee Steven Schwartzberg, Karin Jordan, Sujata Arora, Rudolph M. Navari   +7 more
core   +1 more source

Evaluation of a neurokinin-1 antagonist in preventing multiple-day cisplatin-induced nausea and vomiting

Open Medicine, 2018
To perform a prospective non-randomized comparison of the effectiveness and safety of combined neurokinin-1 antagonist aprepitant treatment with the standard multiple-day cisplatin regimen for the prevention of cisplatin-induced nausea and vomiting (CINV)
Li Quanfu, Wang Wenjuan, Chen Gang, Deng Shuqin, Jiang Caihong, Chen Feng, Zhao Jun, Li Hui, Bai Xiaojun, Hu Yuliang, Da Lenggaowa, Wu Yungaowa, Jin Gaowa   +12 more
doaj   +1 more source

Single center experience on efficacy and safety of Aprepitant for preventing chemotherapy-induced nausea and vomiting (CINV) in pediatric Hodgkin Lymphoma. [PDF]

, 2019
Chemotherapy-induced nausea and vomiting (CINV) is a distressing treatment side-effect that could negatively affect children's quality of life (QoL). Different scoring systems for CINV were applied and different antiemetic drugs were used; however, few ...
Isabella Buffardi, Giuseppe Menna, Rosanna Parasole, Giovanna Giagnuolo, Salvatore Buffardi, Chiara Tortora, Nicoletta Marra, Fara Petruzziello, Giuliana Beneduce, Francesca Rossi   +9 more
core   +1 more source

PENGARUH KECEMASAN TERHADAP KEJADIAN CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) Pengamatan pada pasien kanker payudara stadium awal dengan kemoterapi berbasis antrasiklin [PDF]

, 2013
Background : Chemotherapy induced nausea and vomiting (CINV) is the most troubling adverse effects of cancer treatment that patients cite most often. Despite significant advances in understanding CINV management, nausea and vomiting are still considered ...
, Ahmad Faisal, , dr. Agus Siswanto., SpPD-KPsi.   +1 more
core